ConductScience.org, home

Gene · 6839

NIH grants2,112

NIH grants whose papers are about the gene, through NIH's grant-paper links.

341 to 360 of 2,112

Download this page as JSON
GrantTitleSUV39H1 papersNewest fiscal year
U54CA1630682/2 Ponce Health Sciences University-Moffitt Cancer Center Partnership12025
U54CA163072(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities12025
U54GM104942West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health12025
U54MD007586The RCMI Program in Health Disparities Research at Meharry Medical College12025
U54MD007598Center for Accelerating Excellence in Translational Science (AXIS)12025
UG1CA233259ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center12025
UL1TR001863Yale Clinical and Translational Science Award12025
UL1TR001881UCLA Clinical and Translational Science Institute12025
UL1TR002345Washington University Institute of Clinical and Translational Sciences12025
UL1TR002389The Institute for Translational Medicine12025
UM1AI068616SDMC - IMPAACT Leadership Group12025
UM1AI109565Immune Tolerance Network12025
UM1AI164561Reversing Immune Dysfunction for HIV-1 Eradication12025
ZIAAG000679Epigenetic mechanisms of liver aging12025
ZIAAI000669Molecular Analysis Of Retroviral Genes And Their Products12025
ZIAAI000713Replication mechanisms of human papillomaviruses (HPV)12025
ZIAAI001029Mechanisms of Immune Activation and Disease Progression in Animal Models12025
ZIAAR041126Control of Adult and Aging Myogenesis12025
ZIABC005450Chromatin Structure and Gene Expression12025
ZIABC010027Function of Steroid Receptors in Subcellular Compartments12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6839/grants?page=18